Immunitybio Inc (IBRX) returns
Immunitybio returns over 10 years
$1,000 invested in Immunitybio ten years ago was worth $1,389 at the close on October 30, 2026, with dividends reinvested: an average return of 3.3% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -12.2% | — | $878.18 | -0.9% |
| 3 months | +11.3% | — | $1,113 | +2.1% |
| Year to date | +318.7% | — | $4,187 | +11.7% |
| 1 year | +251.3% | — | $3,513 | +12.4% |
| 3 years | +169.2% | +39.1% | $2,692 | +88.5% |
| 5 years | +5.9% | +1.1% | $1,059 | +76.0% |
| 10 years | +38.9% | +3.3% | $1,389 | +316.6% |
Immunitybio return by calendar year
| Year | IBRX | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +318.7% | +11.7% | +307.0% |
| 2025 | -22.7% | +17.7% | -40.4% |
| 2024 | -49.0% | +24.9% | -73.9% |
| 2023 | -1.0% | +26.2% | -27.2% |
| 2022 | -16.6% | -18.2% | +1.6% |
| 2021 | -54.4% | +28.7% | -83.1% |
| 2020 | +251.7% | +18.4% | +233.3% |
| 2019 | +226.7% | +31.2% | +195.5% |
| 2018 | -74.2% | -4.6% | -69.6% |
| 2017 | -21.5% | +21.7% | -43.2% |
| 2016 | -67.0% | +12.0% | -79.0% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: IBRX financials
No forecast, no recommendation. This page describes Immunitybio Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.